Parole chiave: Iodine 131, Medronate Technetium Tc 99m, Pertechnetic Acid Tc 99m, Adult, Article, Bone Scintiscanning, Case Report, Female, Gamma Spectrometry, Human, Human Tissue, Iodine 131 Uptake Test, Priority Journal, Radiation Absorption, Radioisotope Distribution, Rectum Cancer, Soft Tissue Cancer, Teratoma, Thyroid Follicle, Thyroid Papillary Carcinoma, Thyroidectomy, Whole Body Scintiscanning, Bone And Bones, Dermoid Cyst, Intraoperative Care, Iodine Radioisotopes, Neoplasms, Multiple Primary, Rectal Neoplasms, Sigmoid Neoplasms, Technetium Tc 99m Medronate, Thyroid Neoplasms,
CEB/NIDDK, NIH, 9000 Rockville Pike, Bethesda, MD 20892, United States
A 30-yr-old woman with previously resected papillary thyroid carcinoma was found to have a pelvic lesion which concentrated radioiodine. By performing simultaneous I-131 whole-body and Tc-99m-methylene diphosphonate bone scans, we found the lesion to be in soft tissue between the sacrum and bladder. Radioiodine therapy was postponed so that the lesion, a benign teratoma of the rectal wall, could be surgically removed. Prior to laparotomy, the patient received a second tracer dose of I-131 so that the lesion could be located at surgery with a hand-held gamma detector. A postoperative whole-body I-131 scan confirmed that the lesion had been removed, thus reducing the absorbed radiation that would have been received by the ovaries during radioiodine therapy. Although the lesion contained both thyroid and gastric epithelium, accumulated I-131 was limited to the area with thyroid follicles.
Aloj L, Aurilio M, Rinaldi V, D'Ambrosio L, Tesauro D, Peitl PK, Maina T, Mansi R, Von Guggenberg E, Joosten L, Sosabowski JK, Breeman WA, De Blois E, Koelewijn S, Melis M, Waser B, Beetschen K, Reubi JC, De Jong M * The EEE project(161 visite) Proc Int Cosm Ray Conf Icrc Universidad Nacional Autonoma De Mexico, 2007; 5(HEPART2): 977-980. Impact Factor:0 DettagliEsporta in BibTeXEsporta in EndNote
210 Records (191 escludendo Abstract e Conferenze). Impact factor totale: 573.848 (518.292 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 656.626 (593.539 escludendo Abstract e Conferenze).